论文部分内容阅读
目的评析氨氯地平阿托伐他汀钙片治疗高血压并高血脂的临床效果。方法抽选112例高血压并高血脂患者随机分为各56例的对照组与实验组,分别予以阿托伐他汀钙片、氨氯地平阿托伐他汀钙片治疗,完成8w治疗后以血压、血脂的改善来评估治疗效果,并观察用药安全性。结果对比两组治疗前血压、血脂水平均无明显差异(P>0.05),对比各组治疗前后各项指标均得以改善(P<0.05),而实验组的改善更为显著(P<0.05);两组均未见明显严重不良反应。结论针对高血压并高血脂给予氨氯地平阿托伐他汀钙片治疗有助于患者血压、血脂的有效控制,效果显著,可供临床重视应用。
Objective To evaluate the clinical efficacy of amlodipine atorvastatin calcium in the treatment of hypertension and hyperlipidemia. Methods One hundred and twelve patients with hypertension and hyperlipidemia were randomly divided into control group and experimental group with 56 cases each. The patients were treated with atorvastatin calcium and amlodipine atorvastatin calcium respectively. After 8 weeks of treatment, blood pressure , Improvement of blood lipids to evaluate the therapeutic effect, and observe the safety of medication. Results Compared with before treatment, there was no significant difference in blood pressure and blood lipid (P> 0.05) between the two groups before and after treatment (P0.05), while the improvement in the experimental group was more significant (P0.05) ; No obvious serious adverse reaction was found in both groups. Conclusion Amlodipine atheroscin administration for hypertensive patients with hyperlipidemia is helpful to the effective control of blood pressure and blood lipid in patients with hypertension. The effect is significant and can be clinically valued.